Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-23-responsive immune cells in postoperative recurrent Crohn's disease
NL-OMON53563Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in Crohn's disease, sponsored by Amsterdam University Medical Center. Primary endpoint: Immunological changes in postoperative Crohn's disease. Started Jun 2023; status: recruiting.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON53563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53563.